Search

everythinglearnresearchcommunity

for

Search:↓

miR-199a-3p controls hair growth and is linked to alopecia areata.

People with severe and long-lasting alopecia areata often have low vitamin D levels, and treatments with vitamin D-like substances might help.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Alopecia areata may be linked to heart issues.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Wearing a wig caused a skin condition to develop in a woman with hair loss.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Imbalance in scalp bacteria can affect hair and scalp health, potentially leading to conditions like hair loss, psoriasis, and dandruff.

VKHD and sarcoidosis may share a common cause.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

People with alopecia areata often have thyroid autoimmunity.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Zebrafish are useful for studying and developing treatments for human skin diseases.